Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127636171 | 12763617 | 1 | I | 20160308 | 20160908 | 20160920 | 20160920 | PER | US-TEVA-694076USA | TEVA | 45.00 | YR | F | Y | 0.00000 | 20160920 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127636171 | 12763617 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Unknown | UNKNOWN FORM STRENGTH | U | U | 20622 | ||||||||
| 127636171 | 12763617 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Unknown | U | 0 | ||||||||||
| 127636171 | 12763617 | 3 | SS | REBIF | INTERFERON BETA-1A | 1 | Unknown | U | 0 | ||||||||||
| 127636171 | 12763617 | 4 | SS | AVONEX | INTERFERON BETA-1A | 1 | Unknown | U | 0 | ||||||||||
| 127636171 | 12763617 | 5 | SS | TECFIDERA | DIMETHYL FUMARATE | 1 | Unknown | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127636171 | 12763617 | OT |
| 127636171 | 12763617 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127636171 | 12763617 | Adverse event | |
| 127636171 | 12763617 | Flushing | |
| 127636171 | 12763617 | Multiple sclerosis relapse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |